跳至主要内容
临床试验/IRCT2013012312252N1
IRCT2013012312252N1已完成未知

Evaluation of therapeutic effect of Topiramate augmentation in refractory Obsessive- Compulsive Disorder

Isfahan University Of Medical Sciences0 个研究点目标入组 32 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Obsessive Compulsive criteria according to DSM-IV-TR;
  • Be used maximum tolerated dose of SSRI or Clomipramine for at least 12 weeks;
  • moderate to severe symptoms according to Yale Brown Scale score more than 16;
  • informed consent
  • Exclusion criteria:primary diagnosis of psychotic or mood disorder(bipolar or MDD); subtance abuse or dependence; uncontrolled medical illness(e.g. DM,HTN,...); previous use of Topiramate; pregnancy or breastfeeding or who wants to be pregnant; convulsive disorder; suicidal thought; past history of renal stone

排除标准

  • 未提供

研究者

相似试验